This document is an excerpt from the EUR-Lex website
Document 22011D0096
Decision of the EEA Joint Committee No 96/2011 of 30 September 2011 amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement
Decision of the EEA Joint Committee No 96/2011 of 30 September 2011 amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement
Decision of the EEA Joint Committee No 96/2011 of 30 September 2011 amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement
OJ L 318, 1.12.2011, p. 34–34
(BG, ES, CS, DA, DE, ET, EL, EN, FR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV) This document has been published in a special edition(s)
(HR)
In force
1.12.2011 |
EN |
Official Journal of the European Union |
L 318/34 |
DECISION OF THE EEA JOINT COMMITTEE
No 96/2011
of 30 September 2011
amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement
THE EEA JOINT COMMITTEE,
Having regard to the Agreement on the European Economic Area, as amended by the Protocol adjusting the Agreement on the European Economic Area, hereinafter referred to as ‘the Agreement’, and in particular Article 98 thereof,
Whereas:
(1) |
Annex II to the Agreement was amended by Decision of the EEA Joint Committee No 74/2011 of 1 July 2011 (1). |
(2) |
Commission Directive 2011/10/EU of 8 February 2011 amending Directive 98/8/EC of the European Parliament and of the Council to include bifenthrin as an active substance in Annex I thereto (2) is to be incorporated into the Agreement. |
(3) |
Commission Directive 2011/11/EU of 8 February 2011 amending Directive 98/8/EC of the European Parliament and of the Council to include (Z,E)-tetradeca-9,12-dienyl acetate as an active substance in Annexes I and IA thereto (3) is to be incorporated into the Agreement. |
(4) |
Commission Directive 2011/12/EU of 8 February 2011 amending Directive 98/8/EC of the European Parliament and of the Council to include fenoxycarb as an active substance in Annex I thereto (4) is to be incorporated into the Agreement. |
(5) |
Commission Directive 2011/13/EU of 8 February 2011 amending Directive 98/8/EC of the European Parliament and of the Council to include nonanoic acid as an active substance in Annex I thereto (5) is to be incorporated into the Agreement, |
HAS ADOPTED THIS DECISION:
Article 1
The following indents shall be added in point 12n (Directive 98/8/EC of the European Parliament and of the Council) of Chapter XV of Annex II to the Agreement:
‘— |
32011 L 0010: Commission Directive 2011/10/EU of 8 February 2011 (OJ L 34, 9.2.2011, p. 41), |
— |
32011 L 0011: Commission Directive 2011/11/EU of 8 February 2011 (OJ L 34, 9.2.2011, p. 45), |
— |
32011 L 0012: Commission Directive 2011/12/EU of 8 February 2011 (OJ L 34, 9.2.2011, p. 49), |
— |
32011 L 0013: Commission Directive 2011/13/EU of 8 February 2011 (OJ L 34, 9.2.2011, p. 52).’. |
Article 2
The texts of Directives 2011/10/EU, 2011/11/EU, 2011/12/EU and 2011/13/EU, in the Icelandic and Norwegian languages, to be published in the EEA Supplement to the Official Journal of the European Union, shall be authentic.
Article 3
This Decision shall enter into force on 1 October 2011, provided that all the notifications under Article 103(1) of the Agreement have been made to the EEA Joint Committee (*1).
Article 4
This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union.
Done at Brussels, 30 September 2011.
For the EEA Joint Committee
The President
Kurt JÄGER
(1) OJ L 262, 6.10.2011, p. 31.
(*1) No constitutional requirements indicated.